J MATHENY: Open Payments
NPI 1255325098 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 96 payments from 24 companies in 2025. Trend: 2023 $1,248 · 2024 $1,402 · 2025 $1,677
Food & beverage: $1,677
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $305 |
| AstraZeneca Pharmaceuticals LP | 9 | $217 |
| PFIZER INC. | 11 | $197 |
| Axsome Therapeutics, Inc. | 7 | $196 |
| Amgen Inc. | 6 | $104 |
| Novo Nordisk Inc | 4 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Abbott Laboratories | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| Edwards Lifesciences Corporation | 2 | $48 |
Products named: Auvelity, VRAYLAR, AIRSUPRA, NURTEC ODT, Ozempic, CAPLYTA, EVENITY, UBRELVY.
Industry payments across IN — which companies pay providers there.
